These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16849321)

  • 21. Structural requirements within the lipoyl domain for the Ca2+-dependent binding and activation of pyruvate dehydrogenase phosphatase isoform 1 or its catalytic subunit.
    Turkan A; Gong X; Peng T; Roche TE
    J Biol Chem; 2002 Apr; 277(17):14976-85. PubMed ID: 11842080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the regulation of the mitochondrial alpha-ketoacid dehydrogenase complexes and their kinases.
    Harris RA; Hawes JW; Popov KM; Zhao Y; Shimomura Y; Sato J; Jaskiewicz J; Hurley TD
    Adv Enzyme Regul; 1997; 37():271-93. PubMed ID: 9381974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity.
    Wynn RM; Kato M; Chuang JL; Tso SC; Li J; Chuang DT
    J Biol Chem; 2008 Sep; 283(37):25305-25315. PubMed ID: 18658136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.
    Li J; Kato M; Chuang DT
    J Biol Chem; 2009 Dec; 284(49):34458-67. PubMed ID: 19833728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of protein-protein interactions in the regulation of pyruvate dehydrogenase kinase activity.
    Tuganova A; Popov KM
    Biochem J; 2005 Apr; 387(Pt 1):147-53. PubMed ID: 15504108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications.
    Devedjiev Y; Steussy CN; Vassylyev DG
    J Mol Biol; 2007 Jul; 370(3):407-16. PubMed ID: 17532006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
    Bao H; Kasten SA; Yan X; Roche TE
    Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
    Korotchkina LG; Sidhu S; Patel MS
    Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex.
    Klyuyeva A; Tuganova A; Kedishvili N; Popov KM
    J Biol Chem; 2019 Jan; 294(3):838-851. PubMed ID: 30482839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenic mechanisms underlying X-linked Charcot-Marie-Tooth neuropathy (CMTX6) in patients with a pyruvate dehydrogenase kinase 3 mutation.
    Perez-Siles G; Ly C; Grant A; Drew AP; Yiu EM; Ryan MM; Chuang DT; Tso SC; Nicholson GA; Kennerson ML
    Neurobiol Dis; 2016 Oct; 94():237-44. PubMed ID: 27388934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer.
    Mohammad T; Arif K; Alajmi MF; Hussain A; Islam A; Rehman MT; Hassan I
    J Biomol Struct Dyn; 2021 Feb; 39(2):586-594. PubMed ID: 31903847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates.
    Liu S; Gong X; Yan X; Peng T; Baker JC; Li L; Robben PM; Ravindran S; Andersson LA; Cole AB; Roche TE
    Arch Biochem Biophys; 2001 Feb; 386(2):123-35. PubMed ID: 11368334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural dependence of post-translational modification and reductive acetylation of the lipoyl domain of the pyruvate dehydrogenase multienzyme complex.
    Wallis NG; Perham RN
    J Mol Biol; 1994 Feb; 236(1):209-16. PubMed ID: 8107106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase.
    Steussy CN; Popov KM; Bowker-Kinley MM; Sloan RB; Harris RA; Hamilton JA
    J Biol Chem; 2001 Oct; 276(40):37443-50. PubMed ID: 11483605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assembly and full functionality of recombinantly expressed dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex.
    Yang D; Song J; Wagenknecht T; Roche TE
    J Biol Chem; 1997 Mar; 272(10):6361-9. PubMed ID: 9045657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms.
    Roche TE; Baker JC; Yan X; Hiromasa Y; Gong X; Peng T; Dong J; Turkan A; Kasten SA
    Prog Nucleic Acid Res Mol Biol; 2001; 70():33-75. PubMed ID: 11642366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated function of the pyruvate dehydrogenase phosphatase through Ca2+-facilitated binding to the inner lipoyl domain of the dihydrolipoyl acetyltransferase.
    Chen G; Wang L; Liu S; Chuang C; Roche TE
    J Biol Chem; 1996 Nov; 271(45):28064-70. PubMed ID: 8910418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.
    Kato M; Wynn RM; Chuang JL; Tso SC; Machius M; Li J; Chuang DT
    Structure; 2008 Dec; 16(12):1849-59. PubMed ID: 19081061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy.
    Dahiya R; Mohammad T; Roy S; Anwar S; Gupta P; Haque A; Khan P; Kazim SN; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2019 Sep; 136():1076-1085. PubMed ID: 31233792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.
    Knoechel TR; Tucker AD; Robinson CM; Phillips C; Taylor W; Bungay PJ; Kasten SA; Roche TE; Brown DG
    Biochemistry; 2006 Jan; 45(2):402-15. PubMed ID: 16401071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.